In yesterday’s Wall Street session, Guardant Health Inc. (NASDAQ:GH) shares traded at $36.14, down -4.88% from the previous session.
20 analysts cover Guardant Health Inc. (NASDAQ:GH), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $85.00 and a low of $30.00, we find $53.00. Given the previous closing price of $37.99, this indicates a potential upside of 39.51 percent. GH stock price is now 2.29% away from the 50-day moving average and 6.55% away from the 200-day moving average. The market capitalization of the company currently stands at $4.08B.
The stock has received a hold rating from 3 analysts and a buy rating from 17. Brokers who have rated the stock have averaged $54.18 as their price target over the next twelve months.
In other news, Joyce Meghan V., Director sold 2,766 shares of the company’s stock on Jun 15. The stock was sold for $103,863 at an average price of $37.55. Upon completion of the transaction, the Director now directly owns 4,224 shares in the company, valued at $0.15 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jun 09, Chief Information Officer Kalia Kumud bought 2,981 shares of the business’s stock. A total of $97,498 was incurred on buying the stock at an average price of $32.71. This leaves the insider owning 5,193 shares of the company worth $0.19 million. Insiders disposed of 42,783 shares of company stock worth roughly $1.55 million over the past 1 year. A total of 0.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in GH stock. A new stake in Guardant Health Inc. shares was purchased by JACOBS LEVY EQUITY MANAGEMENT, INC during the first quarter worth $31,241,000. NORGES BANK invested $28,444,000 in shares of GH during the first quarter. In the first quarter, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) acquired a new stake in Guardant Health Inc. valued at approximately $28,153,000. D. E. SHAW & CO., INC. acquired a new stake in GH for approximately $17,733,000. SQUAREPOINT OPS LLC purchased a new stake in GH valued at around $9,398,000 in the second quarter.
On Wednesday morning Guardant Health Inc. (NASDAQ: GH) stock kicked off with the opening price of $37.01. During the past 12 months, Guardant Health Inc. has had a low of $20.67 and a high of $62.75. The fifty day moving average price for GH is $35.45 and a two-hundred day moving average price translates $33.85 for the stock.
According to the Diagnostics & Research Company, earnings per share came in at -$1.3, beating analysts’ expectations of -$1.31 by 0.01. This compares to -$1.21 EPS in the same period last year. The company reported revenue of $128.71 million for the quarter, compared to $96.1 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 33.94 percent. For the current quarter, analysts expect GH to generate $129.41M in revenue.
